RxRxBriefing
Pharma

Sanofi SNY

SanofiPharmaceutical PreparationsI0

Pipeline — registered trials by phase

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
— · Depressive Disorder, Major Depression · Completed · est. 2008-02
GILT Docetaxel - Non-Small Cell Lung Cancer
— · Lung Neoplasms · Completed · est. 2007-01
An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
— · Thyroid Cancer · Completed · est. 2009-07-31
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
— · Gaucher's Disease Type III · Active Not Recruiting · est. 2025-10-02
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year
— · Sleep Initiation and Maintenance Disorders, Insomnia · Completed · est. 2007-11
iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
— · Type 2 Diabetes Mellitus · Completed · est. 2023-10-20
Docetaxel in Head and Neck Cancer
— · Head and Neck Neoplasms · Completed · est. 2010-07
Source: ClinicalTrials.gov (trials where Sanofi is lead sponsor; 69 active or completed) and Drugs@FDA (1 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.

SEC filings — insider trading forms excluded

Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.